Molecular Partners rethinks tetra-specific dosing after seeing 'suboptimal exposure' in cancer trial 0 27.08.2024 17:01 Fiercebiotech.com Molecular Partners rethinks tetra-specific dosing after seeing 'suboptimal exposure' in cancer trial ntaylor Tue, 08/27/2024 - 10:01 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
